Astrana Health (NASDAQ:ASTH) Shares Gap Down – What’s Next?

Astrana Health, Inc. (NASDAQ:ASTH)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $27.22, but opened at $25.41. Astrana Health shares last traded at $21.9770, with a volume of 307,490 shares.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Zacks Research raised Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Monday, January 12th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. BTIG Research lowered their target price on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Jefferies Financial Group reissued a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th. Finally, Barclays cut their price objective on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research report on Monday, November 24th. Eight equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Astrana Health has a consensus rating of “Moderate Buy” and a consensus price target of $41.33.

Astrana Health Price Performance

The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. The firm has a market cap of $1.21 billion, a PE ratio of 113.27, a price-to-earnings-growth ratio of 0.68 and a beta of 0.87. The stock has a 50 day simple moving average of $24.55 and a 200-day simple moving average of $26.96.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.46). Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. The business had revenue of $956.05 million during the quarter, compared to analysts’ expectations of $952.83 million. During the same quarter in the previous year, the firm earned $0.33 earnings per share. Astrana Health’s revenue was up 99.7% on a year-over-year basis. Equities analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Signaturefd LLC boosted its holdings in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after acquiring an additional 871 shares in the last quarter. Covestor Ltd boosted its position in shares of Astrana Health by 210.6% during the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after acquiring an additional 2,192 shares during the last quarter. Tower Research Capital LLC TRC increased its position in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares during the last quarter. Finally, State of Wyoming purchased a new stake in Astrana Health during the second quarter valued at $132,000. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.